How to Invest in IDBI Healthcare Fund Direct Growth?

You can easily invest in IDBI Healthcare Fund Direct Growth in a hassle-free manner on Groww. The process is extremely simple, quick and completely paperless. Invest in a few minutes with the following steps: Log on to your Groww account Search for IDBI Healthcare Fund Direct Growth from the search box In order to invest, you will have to complete all the KYC formalities which are completely online and paperless and take a few minutes to complete Once you are done with that, you can start investing in IDBI Healthcare Fund Direct Growth as SIP or lumpsum as per your investment objective and risk tolerance

What kind of returns does IDBI Healthcare Fund Direct Growth provide?

The IDBI Healthcare Fund Direct Growth has been there from 28 Feb 2019 and the average annual returns provided by this fund is 13.63% since its inception.

How much expense ratio is charged by IDBI Healthcare Fund Direct Growth?

The term Expense Ratio used for IDBI Healthcare Fund Direct Growth or any other mutual fund is the annual charges one needs to pay to the Mutual Fund company for managing your investments in that fund. The Expense Ratio of IDBI Healthcare Fund Direct Growth is 1.22% as of 04 Nov 2025...

What is the AUM of IDBI Healthcare Fund Direct Growth?

The AUM, short for Assets Under Management of IDBI Healthcare Fund Direct Growth is ₹85.19Cr as of 04 Nov 2025.

How to Redeem IDBI Healthcare Fund Direct Growth?

If you want to sell your IDBI Healthcare Fund Direct Growth holdings, go to your holding on the app or web and simply click on it. You will get two options - redeem & invest more; click on redeem and enter your desired amount or if you wish to redeem the entire holding amount then select the 'redeem all' checkbox.

Can I invest in SIP and Lump Sum of IDBI Healthcare Fund Direct Growth?

You can select either SIP or Lumpsum investment of IDBI Healthcare Fund Direct Growth based on your investment objective and risk tolerance.

What is the NAV of IDBI Healthcare Fund Direct Growth?

The NAV of IDBI Healthcare Fund Direct Growth is ₹20.26 as of 28 Jul 2023.

What is the PE and PB ratio of IDBI Healthcare Fund Direct Growth?

The PE ratio ratio of IDBI Healthcare Fund Direct Growth is determined by dividing the market price by its earnings per share and the PB ratio of the same is evaluated by dividing the stock price per share by its book value per share (BVPS).

IDBI Healthcare Fund Direct Growth - NAV, Mutual Fund Performance & Portfolio

<img alt="IDBI Healthcare Fund Direct Growth" srcSet="https://assets-netstorage.groww.in/mf-assets/logos/idbi_groww.png 1x, https://assets-netstorage.groww.in/mf-assets/logos/idbi_groww.png 2x" src="https://assets-netstorage.groww.in/mf-assets/logos/idbi_groww.png" decoding="async" data-nimg="intrinsic" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="companyLogo_companyImage__bT0On absolute-center mfh239Logo" loading="lazy"/>
IDBI Healthcare Fund Direct Growth
Equity
Sectoral-Pharma
High Risk
+13.65%
3Y annualised
+0.55% 1D
1M
6M
1Y
3Y
All
 NAV: 28 Jul 2023
₹20.26
Rating
NA
Min. SIP amount
Not Supported
Fund size
₹85.19Cr
Return calculator
Monthly SIP
One-Time
₹5,000 per month
Over the past
Total investment of ₹0
Would have become ₹ (%)
Holdings (20)NameSectorInstrumentAssets
Sun Pharmaceutical Industries Ltd.
HealthcareEquity16.03%
Divi's Laboratories Ltd.
HealthcareEquity10.66%
Cipla Ltd.
HealthcareEquity8.90%
Dr. Reddy's Laboratories Ltd.
HealthcareEquity8.86%
Apollo Hospitals Enterprise Ltd.
HealthcareEquity8.64%
JB Chemicals & Pharmaceuticals Ltd.
HealthcareEquity6.54%
Torrent Pharmaceuticals Ltd.
HealthcareEquity5.48%
Alkem Laboratories Ltd.
HealthcareEquity4.21%
Abbott India Ltd.
HealthcareEquity4.08%
Syngene International Ltd.
HealthcareEquity3.73%
Ipca Laboratories Ltd.
HealthcareEquity3.44%
Zydus Lifesciences Ltd.
HealthcareEquity2.75%
Aster DM Healthcare Ltd.
HealthcareEquity2.62%
Laurus Labs Ltd.
HealthcareEquity2.40%
Vinati Organics Ltd.
ChemicalsEquity2.26%
Pfizer Ltd.
HealthcareEquity1.82%
Jubilant Ingrevia Ltd.
ChemicalsEquity1.70%
Gland Pharma Ltd.
HealthcareEquity1.33%
Indoco Remedies Ltd.
HealthcareEquity1.21%
Natco Pharma Ltd.
HealthcareEquity1.19%
See All
Minimum investment amountsMin. for 1st investmentNot Supported
Min. for 2nd investment onwardsNot Supported
Min. for SIPNot Supported
Understand termsAnnualised returnsAverage of the yearly returns of a mutual fund over a given period.
Absolute returnsThe total return of a mutual fund over a given period.
Returns and rankingsCategory: Equity Sectoral-Pharma
Annualised returns
Absolute returns
6M1Y3YAll
Fund returnsNA13.6%13.7%17.3%
Category averageNA1.9%21.0%NA
Rank with in categoryNA1310NA
Understand terms
Understand termsExpense ratioA fee payable to a mutual fund house for managing your mutual fund investments. It is the total percentage of a company’s fund assets used for administrative, management, advertising, and other expenses.
TaxA percentage of your capital gains payable to the government upon exiting  your mutual fund investments. Taxation is categorized as long-term capital gains (LTCG) and short-term capital gains (STCG) depending on your holding period and the type of fund.
Exit loadA fee payable to a mutual fund house for exiting a fund (fully or partially) before the completion of a specified period from the date of investment.
Stamp dutyA form of tax payable for the purchase or sale of an asset or security. 
Past expense ratio & exit load
Expense ratio
Exit load
30 Jun 2023 - Present
1.24%
31 May 2023 - 30 Jun 2023
1.24%
30 Apr 2023 - 31 May 2023
1.24%
31 Mar 2023 - 30 Apr 2023
1.24%
28 Feb 2023 - 31 Mar 2023
1.24%
31 Jan 2023 - 28 Feb 2023
1.24%
31 Dec 2022 - 31 Jan 2023
1.24%
31 Dec 2022 - 31 Dec 2022
1.24%
30 Nov 2022 - 31 Dec 2022
1.24%
30 Nov 2022 - 30 Nov 2022
1.24%
30 Nov 2022 - 30 Nov 2022
1.24%
31 Oct 2022 - 30 Nov 2022
1.24%
31 Oct 2022 - 31 Oct 2022
1.24%
31 Oct 2022 - 31 Oct 2022
1.24%
31 Oct 2022 - 31 Oct 2022
1.24%
30 Sep 2022 - 31 Oct 2022
1.24%
30 Sep 2022 - 30 Sep 2022
1.24%
30 Sep 2022 - 30 Sep 2022
1.24%
31 Aug 2022 - 30 Sep 2022
1.24%
31 Aug 2022 - 31 Aug 2022
1.24%
31 Jul 2022 - 31 Aug 2022
1.24%
31 Jul 2022 - 31 Jul 2022
1.24%
30 Jun 2022 - 31 Jul 2022
1.24%
30 Jun 2022 - 30 Jun 2022
1.24%
31 May 2022 - 30 Jun 2022
1.24%
31 May 2022 - 31 May 2022
1.24%
30 Apr 2022 - 31 May 2022
1.24%
30 Apr 2022 - 30 Apr 2022
1.24%
31 Mar 2022 - 30 Apr 2022
1.24%
31 Mar 2022 - 31 Mar 2022
1.24%
28 Feb 2022 - 31 Mar 2022
1.24%
28 Feb 2022 - 28 Feb 2022
1.24%
31 Jan 2022 - 28 Feb 2022
1.24%
31 Dec 2021 - 31 Jan 2022
1.24%
30 Nov 2021 - 31 Dec 2021
1.24%
31 Oct 2021 - 30 Nov 2021
1.24%
30 Sep 2021 - 31 Oct 2021
1.24%
31 Aug 2021 - 30 Sep 2021
1.24%
31 Jul 2021 - 31 Aug 2021
1.24%
30 Jun 2021 - 31 Jul 2021
1.24%
31 May 2021 - 30 Jun 2021
1.24%
30 Apr 2021 - 31 May 2021
1.24%
31 Mar 2021 - 30 Apr 2021
1.34%
28 Feb 2021 - 31 Mar 2021
1.29%
31 Jan 2021 - 28 Feb 2021
1.29%
31 Dec 2020 - 31 Jan 2021
1.40%
30 Nov 2020 - 31 Dec 2020
1.40%
31 Oct 2020 - 30 Nov 2020
1.43%
30 Sep 2020 - 31 Oct 2020
1.28%
31 Aug 2020 - 30 Sep 2020
1.43%
31 Jul 2020 - 31 Aug 2020
1.43%
30 Jun 2020 - 31 Jul 2020
1.43%
31 May 2020 - 30 Jun 2020
1.07%
30 Apr 2020 - 31 May 2020
1.07%
31 Mar 2020 - 30 Apr 2020
1.07%
29 Feb 2020 - 31 Mar 2020
1.07%
31 Jan 2020 - 29 Feb 2020
1.07%
30 Nov 2019 - 31 Jan 2020
1.07%
31 Oct 2019 - 30 Nov 2019
1.07%
30 Sep 2019 - 31 Oct 2019
0.89%
31 Aug 2019 - 30 Sep 2019
0.89%
31 Jul 2019 - 31 Aug 2019
0.89%
30 Jun 2019 - 31 Jul 2019
0.94%
31 May 2019 - 30 Jun 2019
0.94%
30 Apr 2019 - 31 May 2019
0.94%
31 Mar 2019 - 30 Apr 2019
0.82%
Expense ratio, exit load and taxExpense ratio: 1.22%Inclusive of GST
Exit loadExit Load for units in excess of 12% of the investment,1% will be charged for redemption within 90 days.
Stamp duty0.005% (from July 1st, 2020)
Tax implicationReturns are taxed at 20%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 12.5% on returns of Rs 1.25 lakh+ in a financial year.
Understand terms
Check past data
Fund managementKaran Doshi
Jul 2023 - Present
View details
Education
Mr. Doshi is a Bachelor of Engineering, MMS (Finance)
Experience
Prior to joining LIC Mutual Fund, he has worked with Subhkam Ventures Pvt. Limited as Equity Analyst.
Also manages these schemes
LIC MF Unit Linked Insurance Scheme Direct IDCW
LIC MF Aggressive Hybrid Fund Direct Growth
LIC MF Flexi Cap Fund Direct Growth
LIC MF Conservative Hybrid Fund Direct Growth
LIC MF Children's Fund Direct Growth
LIC MF Midcap Fund Direct Growth
LIC MF Dividend Yield Fund Direct Growth
LIC MF Healthcare Fund Direct Growth
LIC MF Consumption Fund Direct Growth
Fund house & investment objective
IDBI Mutual Fund
Rank (total assets)#29 in India
Total AUM₹3,591.62Cr
Date of Incorporation29 Mar 2010
    IDBI Healthcare Fund Direct Growth is a Equity Mutual Fund Scheme launched by IDBI Mutual Fund.     This scheme was made available to investors on 29 Mar 2010.     Uma Venkatraman is the Current Fund Manager of IDBI Healthcare Fund Direct Growth fund.     The fund currently has an Asset Under Management(AUM) of ₹3,592 Cr and     the Latest NAV as of 28 Jul 2023 is ₹20.26.  

    The IDBI Healthcare Fund Direct Growth is rated High risk.     Minimum SIP Investment is set to ₹500.          Exit Load for units in excess of 12% of the investment,1% will be charged for redemption within 90 days.
  ;
Investment ObjectiveThe Scheme seeks to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors. 
 
;
Fund benchmarkBSE Healthcare Total Return Index
Scheme Information Document(SID)
Fund house contact details
Address
4th Floor, IDBI Tower,WTC Complex, Cuffe Parade,Colaba, Mumbai 400005
Phone
NA
Launch Date
29 Mar 2010
E-mail
NA
Website
www.idbimutual.co.in
IDBI Mutual Fund
Asset Management Company
Custodian
SBI SG Global Securities Services Pvt.Ltd.
Registrar & Transfer Agent
KFin Tech
Address
Karvy House, No. 46, 8-2-609/K, Avenue 4,  Street No.1 Banjara Hills,
Email
[email protected]
Website
www.karvymfs.com
DisclaimerThis content is derived from publicly available information, internal sources, and other third-party sources believed to be reliable. We, at Groww Invest Tech Pvt. Ltd. (Formerly known as Nextbillion Technology Pvt. Ltd) (Groww), do not guarantee the accuracy of such information, or assure its completeness, or warrant that such information will not be changed.
All comparisons are done with the category average metrics for this category.
Pros and cons
Category: Equity Sectoral-Pharma
Pros
Lower expense ratio: 1.24%
Cons
Consistently lower annualised returns than category average for the past 1Y and 3Y
Compare funds
IDBI Healthcare Fund Direct Growth
VS
Add mutual fund to compare

Name	Sector	Instrument	Assets
Sun Pharmaceutical Industries Ltd.	Healthcare	Equity	16.03%
Divi's Laboratories Ltd.	Healthcare	Equity	10.66%
Cipla Ltd.	Healthcare	Equity	8.90%
Dr. Reddy's Laboratories Ltd.	Healthcare	Equity	8.86%
Apollo Hospitals Enterprise Ltd.	Healthcare	Equity	8.64%
JB Chemicals & Pharmaceuticals Ltd.	Healthcare	Equity	6.54%
Torrent Pharmaceuticals Ltd.	Healthcare	Equity	5.48%
Alkem Laboratories Ltd.	Healthcare	Equity	4.21%
Abbott India Ltd.	Healthcare	Equity	4.08%
Syngene International Ltd.	Healthcare	Equity	3.73%
Ipca Laboratories Ltd.	Healthcare	Equity	3.44%
Zydus Lifesciences Ltd.	Healthcare	Equity	2.75%
Aster DM Healthcare Ltd.	Healthcare	Equity	2.62%
Laurus Labs Ltd.	Healthcare	Equity	2.40%
Vinati Organics Ltd.	Chemicals	Equity	2.26%
Pfizer Ltd.	Healthcare	Equity	1.82%
Jubilant Ingrevia Ltd.	Chemicals	Equity	1.70%
Gland Pharma Ltd.	Healthcare	Equity	1.33%
Indoco Remedies Ltd.	Healthcare	Equity	1.21%
Natco Pharma Ltd.	Healthcare	Equity	1.19%